Dihexa in low milligram amounts, though Dihexa dosing is poorly standardized given the lack of human trials
"Cerebral Manifestations of Vitamin-B12 Deficiency"
For microdosing protocols , some researchers add 2.5 mL to a 5 mg vial, creating a 2 mg/mL solution
While current therapy of diabetes has targeted glucose control, treatment of diabetic complications, for example, neuropathy, aside from striving for good metabolic control has been only symptomatic
Once absorbed, it is converted to the active coenzyme formsmethylcobalamin and adenosylcobalaminas the body requires them
The most commonly reported effects include: Mild water retention during the first 2 to 4 weeks Occasional headaches, particularly at treatment initiation Redness or irritation at the injection site Tingling or numbness in the extremities Short term fatigue or flushing after injection Ipamorelins selectivity provides a meaningful safety advantage